Greentown Houston has two new automation tools from its corporate partners. Photo via Greentown Labs/LinkedIn

Houston’s Greentown Labs announced new resources and equipment for its members thanks to two corporate partnerships.

Greentown Houston is now home to new tools from Emerson and Puffer to help members implement strong foundations for access to contextualized data.

Automation is the theme with the latest resources, as the process assists with a startup's journey to “standardization and scalability” according to a news release from Greentown Labs. Members will have access to these two units and platforms. The DeltaV Automation Platform is a data-driven decision-making resource that aims to improve operational performance while reducing risks, costs, and downtime. It integrates real-time analytics, advanced automation solutions, sophisticated control systems, and lifecycle services.

Puffer-Sweiven is a localized, single point of contact for sales, service, and applied engineering for Emerson Automation Solutions in the Texas Gulf Coast and Central Texas area with the capabilities to combine with other members in North America to leverage global reach and technologies. Puffer is an Emerson Impact Partner.

With access to the two units, Greentown Labs member companies can further explore easy-to-use, integrated-by-design DeltaV Distributed Control System. With the system, companies and members can better scale new technologies into pilot scale, optimize processes for high quality products, and implement a smart foundation for access to contextualized data. Global ROC is one company that is already utilizing the new resources at Greentown Labs.

“Our member Global ROC, which is developing a solution for cooling tower systems that reduces chemical consumption, saves water, and reduces energy costs, plans to use the system in two ways,” Global ROC CEO Ely Trujillo said to Greentown Labs via LinkedIn.

The startup will be able to create a control method that can be applied to future projects by using and comparing Global ROC’s products with the Delta V’s advanced function blocks. Trujilloalso plans to train team members to set up a Proportional Integral Derivative (PID) controller. The PID involves building a lab test box that connects to the DeltaV’s CHARM modules to control a process to a temperature by varying amperage through the DeltaV’s PID controller.

As part of the 3-year kickoff of the Texas Exchange for Energy and Climate Entrepreneurship (TEX-E), Greentown Labs also celebrated 87 Texas students from The University of Texas at Austin, Texas A&M University, University of Houston, Rice University, Prairie View A&M University, and the Massachusetts Institute of Technology have been accepted into this year's Fellowship. The students will gain access to hands-on experiences including internships, pitch competitions, entrepreneurship bootcamps, courses, and conferences geared to help the climate and energy-transition innovation field.

In

March, Greentown Labs and Browning the Green Space were named the newest accelerator for the Advancing Climatetech and Clean Energy Leaders Program, or ACCEL. The seven selected startups will have a year-long curated curriculum, incubation at Greentown's two locations, and a non-dilutive $25,000 grant.

———

This article originally ran on InnovationMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

Alzheimer’s research

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March.

Dr. Ryan S. Dhindsa is an assistant professor of pathology & immunology at Baylor and a principal investigator at Texas Children’s Duncan Neurological Research Institute (Duncan NRI). He hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation.

“It is an honor to receive this support from the Cure One, Cure Many Award. Viral infections are emerging as a major, underappreciated driver of Alzheimer's disease, and this award will allow our team to conduct the most comprehensive screen of viral exposures and host genetics in Alzheimer's to date, spanning over a million individuals,” Dhindsa said in a news release. “Our goal is to identify which viruses matter most, why some people are more vulnerable than others, and ultimately move the field closer to new therapeutic strategies for patients.”

Roughly 150 million people worldwide will suffer from Alzheimer’s by 2050, making it the most common cause of dementia in the world. Despite this, scientists are still at a loss as to what exactly causes it.

Dhindsa’s research is part of a new range of theories that certain viral infections may trigger Alzheimer’s. His team will take a two-fold approach. First, they will analyze the medical records of more than a million individuals looking for patterns. Second, they will analyze viral DNA in stem cell-derived brain cells to see how the infections could contribute to neurological decay. The scale of the genomic data gathering is unprecedented and may highlight a link that traditional studies have missed.

Also joining the project are Dr. Caleb Lareau of Memorial Sloan Kettering Cancer Center and Dr. Artem Babaian of the University of Toronto. Should a link be found, it would open the door to using anti-virals to prevent or treat Alzheimer’s.